#healthcare #Abu Dhabi #UAE #Insurance #PureHealth

PureHealth Achieves Impressive Growth in H1 2025

In a remarkable display of financial performance, PureHealth Holding PJSC, the leading healthcare group in the Middle East, has reported substantial gains for the first half of 2025. The company achieved an impressive revenue of AED 13.6 billion, reflecting a robust 9% increase compared to the previous year. Alongside this growth, net profit crested at AED 1.03 billion, marking a 2% rise year-on-year.

Strategic Segmentation for Enhanced Efficiency

PureHealth is undergoing significant transformation with a streamlined operating model focusing on two primary verticals – Care and Cover. This new structure integrates all business segments under these categories, where 'Care' includes hospitals, procurement, diagnostics, and technology, while 'Cover' comprises the company’s insurance operations. This approach not only enhances operational efficiency but also improves transparency, allowing investors to gain better insights into the performance of each vertical.

H.E. Kamal Al Maazmi, Chairman of PureHealth, commented that the solid performance is a testament to the group's transformative ambitions. "Our goal is to cultivate a global, forward-thinking healthcare ecosystem that marries technology with compassionate care," he stated.

Similarly, Shaista Asif, the Group's CEO, reiterated the growth in both Care and Cover segments. She emphasized the significance of expanding into the Property and Casualty insurance sector through Daman, which enriches the company’s multi-line coverage. As technology becomes more embedded in the healthcare model, PureHealth is actively enhancing its services through intelligent, AI-driven solutions, which aim to improve healthcare efficiency.

Insights from H1 Financial Performance

The Care segment emerged as the most significant contributor to PureHealth’s revenue, accounting for AED 9.8 billion or 72% of the total. This was an increase of 7% from the previous year. Notably, the Hospitals vertical benefited considerably from a 13% rise in outpatient visits and a 7% increase in inpatient volumes. This growth in the UAE was propelled by expanded service offerings and enhancing specialist capacity across the SEHA and SSMC networks.

In the UK, PureHealth’s Circle Health operation recorded heightened patient engagement with a successful acquisition of Fairfield Independent Hospital, which is set to increase inpatient capacity in a high-demand area.

While there was a 5% dip in procurement revenue, the expansion of the supplier network through Rafed continues to strengthen its integral role in the healthcare delivery model. On another positive note, PureLab reported a remarkable 19% year-on-year surge in testing volume, amplifying operational capacity across the board.

The technology services segment displayed exceptional performance, achieving a staggering 170% revenue markup due to the advancements and digital solutions deployed across the organization.

Meanwhile, the Cover vertical noted a growth of 14%, with Gross Written Premiums rising by 8%. Their consistent focus on crafting new offerings and tapping into less penetrated markets has been key in bolstering their performance.

Future Directions and Strategic Plans

PureHealth's balanced capital allocation framework suggests a commitment to reinvest in core capabilities while also focusing on shareholder returns. The organization is poised to advance its strategic growth through targeted investments in high-margin medical capabilities and fostering international relations to support expansions, such as the anticipated acquisition of Hellenic Healthcare Group in Greece.

In concluding remarks, PureHealth continues to be a pioneering force in redefining healthcare experiences across the Middle East and beyond. These developments not only signify a turnaround in how healthcare is perceived but also emphasize the group's commitment to providing accessible and efficient health solutions.

For further details, please visit PureHealth.